March 12, 2024
Curio Bioscience licenses a novel method from the Broad Institute of MIT and Harvard to fuel the next generation of discovery research PALO ALTO, Calif. – Curio Bioscience today announced the commercialization of the world’s first technology that spatially contextualizes single-cell sequencing data, leveraging a breakthrough invention called Slide-tags developed by the Broad Institute of MIT [...]
Daiichi Sankyo Adopts Genedata Biologics to Automate the Discovery of Novel Biological Therapeutics
March 12, 2024
Global leader in Biopharma R&D chooses the Genedata Biopharma Platform to accelerate discovery timelines for protein-based modalities Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced today that Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan, has adopted Genedata Biologics® to automate its discovery workflows. The [...]
March 12, 2024
HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif. -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the PureTarget repeat expansion panel, a new solution designed to enable the comprehensive analysis of 20 genes associated with serious neurological disorders, including challenging-to-sequence genes [...]
908 Devices Trace Chemical Identification Technology Adopted by European Agencies
March 12, 2024
Fostering Relationships with the NATO Support and Procurement Agency and the DrugDetect EU project, 908 Devices’ MX908 Deployed Across Europe for Trace Chemical Detection and Identification BOSTON -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for [...]
Rigaku Opens Taiwan Branch to Enhance Collaboration and Innovation
March 12, 2024
TOKYO -- Rigaku, a global solution partner in X-ray-analysis proudly announces the opening of its new Rigaku Taiwan Branch ("RCTW"). This expansion marks a significant milestone in Rigaku's longstanding commitment to advancing the semiconductor electronics, life and material science ecosystem, particularly in Taiwan, a critical region for technological advancement. Technical supports offered by RCTW underscores [...]
2024 Testa Challenge launches focusing on antibody-drug conjugates
March 12, 2024
Antibody-drug conjugates are gaining traction as an alternative or complementary therapy for different types of cancers Contest opened March 11, 2024; five winners will spend three weeks in Uppsala, Sweden testing their innovations Biotech firms and academic researchers interested in accessing a live bioprocess run for their technical and digital innovation projects are encouraged to [...]
March 12, 2024
Opentrons for Education transforms the classroom experience by introducing lab automation into educational settings By empowering educators with user-friendly automation tools, this program ensures students gain invaluable skills that are crucial for their future careers BROOKLYN, N.Y. -- Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the [...]
March 12, 2024
– An Invitae-developed innovative approach to help reduce variants of uncertain significance – SAN FRANCISCO -- Invitae (OTC: NVTA), a leading medical genetics company, today announced the launch of an update to Invitae Generation™ with Clinical Variant Modeling, a novel machine learning approach designed to aid clinical interpretation of genetic testing results and increase the rate of definitive [...]
Element Biosciences Announces Senior Vice President of Global Sales and Support
March 12, 2024
SAN DIEGO -- Element Biosciences, Inc., developer of pioneering technologies to empower science, today announced the appointment of Danae Van Oene as Senior Vice President of Global Sales and Support. In her new role, Danae will spearhead Element's commercial sales initiatives, overseeing regions including North America, Asia Pacific, EMEA, Latin America and others worldwide. As Element expands its [...]
Tierra Biosciences Secures $11.4M Series A Funding Round Led by Material Impact
March 12, 2024
Company to Provide Broader Access to its AI-Driven Cell-Free Protein Production Platform SAN LEANDRO, Calif. -- Tierra Biosciences, the company behind the world’s first platform for predictive AI-guided cell-free technology enabling high-throughput on-demand custom protein synthesis, announced today that it closed an $11.4M Series A round. The investment was led by Material Impact with participation from new [...]

